Alliance Wealth Advisors (Utah)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$560K Buy
+1,772
New +$418K 0.11% 120

Other funds holding LGND

Alliance Wealth Advisors (Utah)'s LGND Position: Q2 2026 in Review

Alliance Wealth Advisors (Utah) opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 1,772 shares worth $560K. The stake represents 0.11% of the portfolio and ranks #120 among its holdings.

71 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Alliance Wealth Advisors (Utah) held 1,772 shares of Ligand Pharmaceuticals worth $560K as of Q2 2026.
  • Ligand Pharmaceuticals was a new Alliance Wealth Advisors (Utah) position in Q2 2026.
  • Ligand Pharmaceuticals made up 0.11% of Alliance Wealth Advisors (Utah)'s portfolio in Q2 2026, its #120 holding.
  • 71 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.